Genmab is a biotech company engaged in the development of human antibody therapeutics for the treatment of cancer in Denmark and internationally. The company has one product on the market, ofatumumab, and is developing a pipeline of fully human antibody therapeutics for the treatment of cancer. Genmab’s clinical product pipeline includes ofatumumab, daratumumab (HuMax® -CD38) and RG1512 (developed under collaboration with Roche). For further information, visit the company’s Web site at www.genmab.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: